Not Yet RecruitingNot Applicable

Virtual Reality Distraction for Pain and Anxiety in Hemodialysis Patients

Iraq150 participantsStarted 2025-12-25

Plain-language summary

1. Assess pain and anxiety levels in hemodialysis patients during arteriovenous fistula needle insertion. 2. Determine the effect of the distraction technique using virtual reality on pain and anxiety levels during arteriovenous fistula needle insertion in hemodialysis patients. 3. Find out the differences in the level of pain and anxiety after using virtual reality with regard to the demographic and clinical data of the sample.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients with End-Stage Renal Disease (ESRD) on hemodialysis. * Patients using a functioning arteriovenous fistula (AVF). * Conscious, oriented, and able to communicate. * Normal or corrected vision and hearing suitable for VR use. * Patients capable of giving written informed consent. Exclusion Criteria: * History of motion sickness, seizures, or epilepsy. * Use of Central Venous Catheter (CVC) or Arteriovenous Graft (AVG). * Use of analgesics or sedatives within 4 hours before the procedure. * Facial wounds or eye infections preventing VR use. * Hemodynamic instability or cognitive impairment.

What they're measuring

pain intensity

Timeframe: Immediately after the needle insertion procedure

Anxiety Level

Timeframe: Immediately after the needle insertion procedure

Trial details

NCT IDNCT07334522

SponsorKarbala University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-25

Contact for this trial

Astabraq R Hussien, MGS

+9647718107352 astabraq.r@s.uokerbala.edu.iq

View on ClinicalTrials.gov More Pain Management trials